Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 1, 2000 - Issue 5
Submit an article Journal homepage
270
Views
18
CrossRef citations to date
0
Altmetric
Miscellaneous

Rofecoxib

Jan L Hillson Virginia Mason Medical Centre and Virginia Mason Research Centre, 1100 Ninth Avenue, Seattle, WA 98101, USA.
&
Daniel E Furst Virginia Mason Medical Centre and Virginia Mason Research Centre, 1100 Ninth Avenue, Seattle, WA 98101, USA.
Pages 1053-1066 | Published online: 24 Feb 2005

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Werner Kiefer & Gerd Dannhardt. (2005) COX-2 inhibition and pain management: a review summary. Expert Review of Clinical Immunology 1:3, pages 431-442.
Read now

Articles from other publishers (17)

Wei Liu, Zexin Wang, Renfu Li, Liwei Chen, Xiang Lin, Shitao Sun, Zhenli Li, Jinle Hao, Bin Lin, Xinli Wang & Lijun Xie. (2022) ACQ-to-AIE Transformation by Regioisomerization of Rofecoxib Derivatives for Developing Novel Mechanochromic and Acidochromic Materials. Journal of Molecular Structure 1260, pages 132728.
Crossref
Xia Du, Lintao Zhao, Yuan Qiao, Yuan Liu & Dong Guo. (2022) The System Research of the Molecular Mechanism of Quyushengxin Capsule in the Treatment of Osteonecrosis of the Femoral Head. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-11.
Crossref
Rozires P. Leão, Josiane V. Cruz, Glauber V. da Costa, Jorddy N. Cruz, Elenilze F. B. Ferreira, Raí C. Silva, Lúcio R. de Lima, Rosivaldo S. Borges, Gabriela B. dos Santos & Cleydson B. R. Santos. (2020) Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach. Pharmaceuticals 13:9, pages 209.
Crossref
Luísa C. R. Carvalho, Daniela Ribeiro, Raquel S. G. R. Seixas, Artur M. S. Silva, Mariana Nave, Ana C. Martins, Stefan Erhardt, Eduarda Fernandes, Eurico J. Cabrita & M. Manuel B. Marques. (2015) Synthesis and evaluation of new benzimidazole-based COX inhibitors: a naproxen-like interaction detected by STD-NMR. RSC Advances 5:61, pages 49098-49109.
Crossref
Jason T. Bau & Ebba U. Kurz. (2011) Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha. Biochemical Pharmacology 81:3, pages 345-354.
Crossref
Naveen Ahuja, Amarjit Singh & Bhupinder Singh. (2003) Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. Journal of Pharmacy and Pharmacology 55:7, pages 859-894.
Crossref
C. Hünseler, B. Roth, E. Michel, G. Dubbel & B. Zernikow. 2009. Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen. Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen 75 130 .
Ray Truant, Lynn A. Raymond, Jianrun Xia, Deborah Pinchev, Anjee Burtnik & Randy Singh Atwal. (2014) Canadian Association of Neurosciences Review: Polyglutamine Expansion Neurodegenerative Diseases. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 33:3, pages 278-291.
Crossref
Paul J. Desjardins, Donald R. Mehlisch, David J. Chang, David Krupa, Adam B. Polis, Richard A. Petruschke, Kerstin Malmstrom & Gregory P. Geba. (2005) The Time to Onset and Overall Analgesic Efficacy of Rofecoxib 50 mg. The Clinical Journal of Pain 21:3, pages 241-250.
Crossref
B. Roth, C. Hünseler, E. Michel & B. Zernikow. 2005. Schmerztherapie bei Kindern. Schmerztherapie bei Kindern 69 120 .
Fran Norflus, Agnes Nanje, Claire-Anne Gutekunst, Geming Shi, Joshua Cohen, Michelle Bejarano, Jonathan Fox, Robert J. Ferrante & Steven M. Hersch. (2004) Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice. Neurobiology of Disease 17:2, pages 319-325.
Crossref
Alan J. Kivitz, Maria W. Greenwald, Stanley B. Cohen, Adam B. Polis, Daryl K. Najarian, Mary E. Dixon, Robert A. Moidel, Jerry A. Green, Herbert S. B. Baraf, Richard A. Petruschke, Alan K. Matsumoto & Gregory P. Geba. (2004) Efficacy and Safety of Rofecoxib 12.5âmg Versus Nabumetone 1,000âmg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial. Journal of the American Geriatrics Society 52:5, pages 666-674.
Crossref
Javier P. Gisbert & José María Pajares. (2003) Ciclooxigenasa-2 y lesiones gastroduodenales. ¿Alguna relación con Helicobacter pylori ?. Medicina Clínica 120:14, pages 550-558.
Crossref
Javier P. Gisbert & José María Pajares. (2003) Ciclooxigenasa 2 (COX-2), Helicobacter pylori y cáncer gástrico. Medicina Clínica 120:5, pages 189-193.
Crossref
B. Roth, C. Hünseler, E. Michel & B. Zernikow. 2003. Schmerztherapie bei Kindern. Schmerztherapie bei Kindern 81 144 .
Robert W. McMurray & Kenneth J. Hardy. (2002) Cox-2 Inhibitors: Today and Tomorrow. The American Journal of the Medical Sciences 323:4, pages 181-189.
Crossref
George E. Ehrlich. (2001) Erosive osteoarthritis: Presentation, clinical pearls, and therapy. Current Rheumatology Reports 3:6, pages 484-488.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.